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Abstract To date, little is known about the psychosocial
aspects of preconception consultation (PCC) in primary
care. PCC in primary care is appropriate for couples and
individuals with a reproductive wish. In PCC, non-genetic
and genetic risk factors may be identified. Focusing on non-
genetic and genetic risk factors in PCC requires the use of
different counselling strategies and tools in optimizing the
outcome of pregnancy. Addressing lifestyle alterations
requires directive counselling, whereas addressing in-
creased genetic risk and its subsequent reproductive
options requires non-directiveness. When an increased ge-
netic risk is detected, couples should be informed about their
possibilities for not passing on a disease allele. Depending
upon the various modes of inheritance and reproductive
options, couples may face a variety of psychosocial chal-
lenges. This paper aims to provide insights into the psycho-
social impact of the genetic aspects of PCC by drawing upon
literature and clinical experience in the Clinical Genetics
department. Furthermore, this paper provides consideration
for future developments regarding preconception genetic
screening.
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Preconception care
Preconception care is one of the main instruments of high-
income countries to reduce stillbirth rates (Flenady et al. 2011).
In 2007, the Dutch Health Council recommended to initiate
preconception care by means of a central programme. Since
2006, a rapidly growing number of midwifery practices have
started offering preconception consultation (PCC) in the Neth-
erlands. Preconception care has thus become more integrated
in primary health care, thereby increasing the uptake. The sole
indication for preconception care is the wish or consideration
to become pregnant. PCCmay focus on lifestyle and work and
living environment issues, medicine use and advice to use folic
acid supplements, advanced parental age, consanguinity,
smoking/alcohol/drugs (ab)use, teratogens, infectious diseases,
chronic disease of the woman, previous gynaecological prob-
lems (miscarriages, labour problems), congenital anomalies or
hereditary disease of the woman or man, a previous child with
a congenital anomaly or hereditary disease, family history with
a congenital anomaly or a (possible) hereditary disease (Atrash
et al. 2008). Thirty couples receiving PCC in a Dutch trial had
an average of six risk factors per couple (De Jong-Potjer et al.
2003). According to a 2010 WHO report on community
genetics in middle- and low-income countries, genetic compo-
nents of primary preconception care include: detection of
genetic risks through family history, addressing the issue of
consanguinity if relevant, explaining programmes of preven-
tion of congenital disorders and genetic diseases that exist in
the community, and genetic counselling as appropriate (Al-
Arrayed et al. 2010). In the Netherlands, the request has been
made to add preconception carrier screening of cystic fibrosis
(CF) and heamoglobinopathies (HbPs) to primary preconcep-
tion care (Cornel et al. 2011; van Elderen et al. 2010). In 2007,
the advisory report ‘Preconception care: a good beginning’
advised that preconception screening may be offered for CF
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and HbPs in the Netherlands (Netherlands HCot 2007). To
date, this screening has not been implemented.
If preconception genetic screening for autosomal reces-
sive disorders such as CF and HbPs is offered in the setting
of PCC, then couples should receive adequate counselling.
Couples should be informed about what carriership implies
for them personally, for their families and for their repro-
ductive options. Depending upon the chosen reproductive
option, couples may face a variety of psychological chal-
lenges. To date, research focusing on the psychosocial impact
of genetic counselling in preconception care is scarce. This
paper aims to provide insights into the psychosocial impact of
genetic counselling in preconception care by drawing upon
literature and clinical experience in the Clinical Genetics
department. This paper will focus on two themes regarding
genetic counselling in preconception care: counselling and its
psychological impact.
Counselling of non-genetic and genetic aspects in PCC
When non-genetic risk factors are identified in PCC, informa-
tion is provided to enable couples to change their behaviour in
ways that are beneficial to the pregnancy. Pregnancy may be
positively influenced by starting a healthy diet, losing weight,
taking folic acid supplements, tobacco, alcohol and drugs
cessation, and taking part in regular exercise. As the stages of
change model illustrates (Prochaska et al. 1994), in order to
adjust behaviour, more than information is required. A counsel-
ling aimed at changing behaviour should be directive and
should comprise an assessment of the stage of change a person
is in, and following the stage either information, or more
practical advice, empowerment or reinforcement is necessary.
When an increased genetic risk is identified in PCC,
information is provided to enable couples to make informed
decisions about their options for not passing on a disease
allele to their offspring or to reduce the risk of an affected
live born child. Contemplating the impact of (possibly)
developing a (un)treatable disease in the future, and consid-
ering the options for not passing on a disease allele require
that the counselee is offered information and a non-directive
discussion in which the counselee works through the various
scenarios she or he might be facing. She or he then needs to
evaluate which of the options fits best with her or his
capacity and personal values. An indication for referral to
a clinical genetics centre may be identified during PCC. A
couple will then have to decide whether or not they wish to
engage in further genetic counselling. Given the possible
consequences of risk estimation or genetic testing, it is
important that a couple is offered non-directive counselling
as part of genetic PCC to assist them in this decision as well.
Thus, focusing on genetic and non-genetic risk factors in
preconception counselling requires the use of different
counselling strategies, namely directive and non-directive
counselling, respectively, and different interventions in opti-
mizing the outcome of pregnancy. This is important because it
implies that the counsellor in PCCwill have to be able to switch
counselling strategies as appropriate during the consultation.
Reproductive options
If couples are at increased genetic risk or are offered genetic
preconception screening, they should be informed about the
reproductive options that are available to them. When cou-
ples are proven carriers of a disease allele, they may opt for
prenatal diagnosis (PND), preimplantation genetic testing
(PGD), sperm or egg cell donation, natural conception or
refraining from having children. The non-directive approach
in the counselling implies that the counsellor does not have
a preference with regard to engaging in genetic screening or
with respect to reproductive options. The counsellor aids the
couple in discovering what the best option is for them.
Prenatal diagnosis
In PND, chorionic villus sampling and amniocentesis are
invasive methods to collect foetal material (Raymond et al.
2010). Both methods carry a small risk of miscarriage. Cho-
rionic villus sampling is possible at 10–13 weeks gestation,
and the test result may be known before 14 weeks gestation.
This implies that pregnancy may be ended by means of
curettage. Amniocentesis is performed around 15–17 weeks
gestation, and the test result may be known after approximate-
ly 2–3 weeks. In case of an affected foetus, the pregnancy may
be ended by inducing labour in a hospital setting.
When there is an increased risk for a structural congenital
anomaly in offspring, PND by advanced ultrasound exam-
ination is frequently possible. Detecting an anomaly pro-
vides the opportunity to influence the course of the
pregnancy. However, normal ultrasound findings are not
informative for all anomalies/disorders (e.g. anal atresia or
learning disabilities). Our clinical impression is that this
subgroup of at-risk individuals may experience a significant
amount of distress because they know there is an increased
risk of affected offspring, but they have no options to reduce
this risk. In the Netherlands, couples may decide to end the
pregnancy by labour induction before 24 weeks of gestation.
In the near future, it is expected that non-invasive prena-
tal diagnosis (genetic analysis on foetal DNA extracted from
maternal blood) will be possible for a limited number of
indications. The major advantage of this type of PND is the
avoidance to a large extent of the abortion risk.
Research showed that the psychological impact of preg-
nancy termination increased as gestational age advanced
214 J Community Genet (2012) 3:213–219
(Davies et al. 2005). Overall, women experienced intense
grief, trauma, psychological complaints and pressure on the
partner relationship after late pregnancy termination
(>16 weeks gestation) and occasionally regret (Korenromp
et al. 2006). While most women were able to resolve their
grief, more than one third of the women still experienced
elevated levels of trauma and grief up to 4 years after the
pregnancy termination (Davies et al. 2005; Korenromp et al.
2005a; Hunfeld et al. 1997; Korenromp et al. 2007). Because
of the impact of ending a desired pregnancy, it is important
that couples are prepared for all the issues involved in the
decision whether or not to opt for PND. The severity of the
condition, its treatability, the family history of the condition
and the couples’ attitude towards pregnancy termination all
contribute to the couple’s perception of the disease and their
motivation for PND. Couples who have lost relatives or
witnessed the symptoms of a disease may be more motivated
to prevent passing on the disease allele and opt for PND, and
may experience fewer doubts than couples who have not
witnessed the disease. Couples do not always agree on wheth-
er they wish to have PND. In our clinical experience, men are
more inclined to opt for PND than women. Moreover,
research has shown that women and men also respond differ-
ently to pregnancy termination. Women experienced more
grief and trauma from pregnancy termination than men, but
women receiving partner support generally coped better
(Korenromp et al. 2005b; Geerinck-Vercammen and Kanhai
2003). For the quality of the partner relationship, it is impor-
tant that couples resolve their differences and decide about
PND in unison.
Preimplantation genetic diagnosis
In our experience, couples generally perceive PGD as an
option when ending a pregnancy is not an option or when
they already need IVF due to decreased fertility. In the
Netherlands, there is a committee reviewing PGD requests.
As a guideline, each condition that is an indication for PND
is also an indication for preimplantation genetic diagnosis
(PGD); however, there are exceptions (Geraedts and De
Wert 2009). PGD involves in vitro fertilization, testing
the embryo genetically and transferring it to the uterus
only if it is not carrying the disease allele (van Rijn et al.
2011). PGD requires considerable time and effort, with a
pregnancy rate of around 15–20 % each trial (http://
www.pgdnederland.nl/). A recent pilot study indicated that
women undergoing PGD had increased anxiety scores
around the time of fertilization and pregnancy testing, but
did not take into account the whole procedure of PGD (e.g.
being on the waiting list whilst experiencing a strong repro-
ductive wish, etc.) (Karatas et al. 2011). In our clinic,
couples having experienced PGD indicated they found
PGD quite burdensome. Couples are offered psychosocial
counselling during the PGD process.
The psychological function of pregnancy
Surprisingly, few studies have evaluated the psychological
impact of preconception counselling. In order to grasp the
possible psychological impact of being confronted with
genetic risk during preconception consultation, it is impor-
tant to understand the psychological function of pregnancy.
It may be assumed that couples, who wish to be informed
about genetic risks, express their wish to have children and
at the same time feel responsible for the future child’s health
and welfare. Hence, from a psychodynamic point of view, the
couple’s decision to plan a pregnancy represents a develop-
mental milestone and a psychosocial crisis (Leon 1992a). First,
the outlook on parenthood might give each of the couple an
independent sense of adult identity with different perspectives
for the prospective mother and father. In case of hereditary
risks, we have often observed that the mother is particularly
concerned with the welfare of the future child, whereas the
father feels protective towards the entire family system (e.g. the
well-being of the other children in the family, maintenance of
quality of life of the family). Second, to both prospective
parents, a pregnancy means an enhancement of the self and
one’s own importance, and achievement of omnipotent feel-
ings, which may be challenged when the pregnancy is threat-
ened by hereditary risks. Third, longing for a pregnancy also
implies that the couple wishes to create a new object relation-
ship which underlines the increasing identification with paren-
tal figures in past and present (Leon 1992b). All of these
psychodynamic functions of pregnancy may be threatened
when couples discover their genetic risk.
When couples are offered PCC and are informed about
the genetic risks for future children, they become aware of
the tension between the desire to have, nurture and raise a
child on the one hand and their sense of responsibility on the
other hand. Parents may experience guilt feelings towards
(future) offspring (Strømsvik et al. 2009; van Oostrom et al.
2007; Klitzman et al. 2007).
Confrontation with genetic risks and appeal to the feel-
ings of responsibility towards the future child and others
involved may attenuate the desire for a pregnancy. More-
over, the marital relationship may be challenged when one
member of the couple feels differently than the other with
regard to the need to have PCC and the subsequent man-
agement (reproductive screening/testing) options, especially
if one member of the couple has multiple risk factors and
difficulties to adapt. While PCC has a highly informative
character for couples, in general, it can be said that PCC
may alter the subsequent pregnancy experience. Once in-
formed of one’s genetic risks, the idealized representation of
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pregnancy dissipates. The information that a genetic risk
exists and the availability of genetic testing or screening
may increase the social pressure to seriously consider and
apply for screening (van Elderen et al. 2010).
The psychosocial impact of genetic risk and carriership
Regardless of whether preconception screening for certain
autosomal recessive disorders is implemented, couples may
be confronted with a genetic risk during PCC based on their
family history. Couples who attend the Clinical Genetics
department are anticipating learning about their genetic risk,
whereas learning about an increased genetic risk during
PCC may catch couples by surprise. Studies evaluating the
psychological impact of PCC are scarce. The few studies
that were conducted expected PCC to elicit anxiety; how-
ever, it was found that anxiety levels did not increase after
preconception counselling (de Weerd et al. 2001; De Jong-
Potjer et al. 2006), and in contrast, some subgroups experi-
enced a decline in anxiety after preconception counselling.
In Clinical Genetics, more research has focused on the
psychological impact of genetic risk and carriership. Various
modes of inheritance also present with a variety of psycho-
social issues that may be relevant in aiding couples deciding
about engaging in further genetic testing. Furthermore,
depending upon the mode of inheritance, different reproduc-
tive options may apply that each have differing psycholog-
ical challenges. The PCC counsellor should be aware about
these issues to adequately prepare couples for the decisions
and implications that may follow genetic screening or testing.
In case of a balanced chromosomal rearrangement (e.g.
translocation, inversion) in the family, couples may present
for carriership testing. These couples may be referred for
PCC after recurrent miscarriage or a previous affected child
(due to an unbalanced chromosomal rearrangement).
Depending on the type of balanced chromosomal rearrange-
ment in the parent, recurrence risk for an unbalanced chro-
mosomal rearrangement in the offspring may be lower or
higher (McKinlay Gardner and Sutherland 2004). It is our
experience that some couples with recurrent miscarriage and
couples with a previous child with a de novo unbalanced
chromosomal rearrangement may hesitate about prenatal
diagnosis (PND) due to the (small) miscarriage risk of
invasive prenatal diagnosis. Some of them express the wish
to perform advanced ultrasound examination, which is not
the golden standard for chromosomal aberrations. In addi-
tion, women with a high recurrence risk of miscarriage may
experience high levels of anxiety (Vansenne et al. 2011).
In case of X-linked (recessive) disorders such as Fragile
X or Duchenne muscular dystrophy, a woman may be
carrying a mutation from which she experiences no or mild
symptoms, but that may cause her sons to be severely
affected. Although daughters often are healthy, prospective
mothers may find it undesirable for their daughters to be
carriers. In the clinic, we have observed women who
objected to passing on their reproductive issues to their
daughters. Mothers who were proven carriers with an af-
fected child were more inclined to change their reproductive
plans (Lewis et al. 2011). Research has shown that mothers
of children affected by X-linked disorders had a rather
strong tendency to experience feelings of guilt and self-
blame, often reinforced by the father who may blame the
mother as well (James et al. 2006). Given the difficulties
carrier women have in disseminating the information to at-risk
relatives, recommendations are to offer women support to
ensure that relatives with a reproductive wish are informed
in a timely manner about their own risk for transmitting the
disease allele (van Rijn et al. 1997).
In case of an autosomal recessive disorder in the family,
such as cystic fibrosis (CF), couples may present for carrier-
ship testing. These couples often are aware of the disease
because of their family history. Generally, heterozygosity, in
case of CF, has no consequences for the health of the
prospective parents (Read and Donnai; in this issue). Studies
into screening for CF found that carriers were not greatly
distressed about their personal test result. However, if both
partners were carrying a CFTR mutation, they may feel
distressed about the increased risk for their offspring (Watson
et al. 1992). Another study found that carriers reported no
impact of the test result on their reproductive plans (Henne-
man et al. 2002). In case of screening, there is generally no
positive family history of CF and couples may have a less
vivid image of what CF may be. Studies showed that parents
of a child with CF choose to have PND in 20 to 65 % of cases
(Evers-Kiebooms et al. 1990; Borgo et al. 1992; Jedlicka-
Köhler et al. 1994), but carrier–carrier couples opted for
PND in 28 out of 31 cases (90 %) (Super et al. 1994; Brock
1996). Couples may be less prepared to accept a miscarriage
risk when they have already had the experience of bearing and
raising a child. In case of autosomal recessive disorders,
couples may have trouble understanding their reproductive
risks (James et al. 2006). Several studies have consistently
reported that recall and understanding of genetic risk is poor
(Austin 2010; Smerecnik et al. 2009).
When one of the prospective parents is at increased risk
of transmitting a known autosomal dominant disorder such
as Huntington disease (HD), carrier testing is an option in
order to determine whether one’s offspring is at increased
risk as well. Genetic counsellors view the discussion of
reproductive options as one of the five main themes of the
counselling for HD (Hines et al. 2010). These individuals
often indicate that in the absence of a reproductive wish they
would not opt for testing. However, the test not only gen-
erates knowledge about the risks of the child but also about
the future health of the prospective parent. In counselling,
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much attention is paid to the psychosocial aspects of receiving
an unfavourable test result for oneself. Positive carrier testing
could result in lowered self-esteem, stigmatization, discrimi-
nation and denial of health and life insurance, and employ-
ment opportunities (Markel 1992; Lakeman et al. 2009).
Couples of whom one is an HD-mutation carrier might
decide not to postpone starting a family. However, they may
neglect that the children will be exposed to potentially
intrusive or even traumatic experiences with an affected
parent in early childhood. Research has shown that individ-
uals exposed to an affected parent early in childhood more
often had an insecure attachment representation, which is
associated with worse adult functioning (Van der Meer et al.
2006). This issue may be addressed in genetic PCC.
Female carriers of the breast cancer 1 or 2 disease allele
represent a special case for genetic PCC. These women are
at increased risk for breast and ovarian cancer, raising three
reproductive issues: the use of contraceptives, preventive
surgery and breastfeeding, and the possibility of prenatal diag-
nosis (Quinn et al. 2009), all of which should be addressed in
genetic PCC.
There is strong scientific support for the idea that major
psychiatric illnesses such as bipolar disorder, autism, alcohol-
ism, schizoaffective disorder and schizophrenia are caused by
the combined influences of both genetic and environmental
contributions (Austin and Peay 2006). Both affected and
healthy individuals may have concerns about passing on
susceptibility for psychiatric conditions to their offspring.
The combined influence of genetics and environment may
easily lead to misunderstanding of genetics and over- or
underestimation of risks. Consequently, this may lead to deci-
sions which would otherwise not be made. If individuals with
a psychiatric disorder request genetic PCC, special attention
should be paid to the tension between ‘desire for a child’ and
responsibility as individuals with a psychiatric disorder may
have above average problems with information processing,
balancing considerations and emotion regulation.
Discussion
When couples engage in PCC, they may be confronted with
increased genetic risk based on their family history. It is
expected that in the near future, PCC will also comprise the
offer of carrier screening for CF and HbPs.
PCC providers should be aware of the different counselling
strategies that are appropriate when focusing on non-genetic
and genetic risk factors in PCC. When focusing on non-
genetic risk factors, directive counselling is a more adequate
approach influencing behaviour (medicine use, healthy life-
style, drug cessation, etc.). When focusing on genetic screen-
ing and (the consideration of) testing, a non-directive approach
is necessary. Non-directiveness enables couples to process
relevant information and reach their own decision regarding
whether they wish to engage in genetic screening or testing.
Even though studies demonstrated that carrier screening for CF
and HbPs did not elicit adverse psychological effects (Watson
et al. 1992; Lakeman et al. 2008), proven carriership is likely to
be unexpected to couples without a family history. The lessons
from Clinical Genetics are that couples should be enabled to
consider beforehand what consequences screening might have
and whether they are willing and able to accept these, and to
anticipate these consequences, especially since couples indi-
cated they would use this knowledge for their reproductive
decisions (Lakeman et al. 2008). Here lies an important task for
the providers of PCC. In our view, decision counselling re-
garding preconception genetic screening should address the
genetic risks of conceiving an affected child, the possible
treatment options, the possibilities to prevent passing on the
disease allele, and its consequences, the psychological impact
of the various possibilities and the meaning of these possibil-
ities to the couple. Therefore, the PCC counsellor must be
skilled in directive and non-directive counselling and must
have knowledge of the relevant reproductive options and
associated psychological challenges in case of carriership
or in case an indication for referral to a Clinical Genetics
centre is found.
The PCC counsellor should be aware that genetic and non-
genetic risks pose a threat to the idealized pregnancy. A
pregnancy, or anticipated pregnancy, fulfils a number of psy-
chological functions (sense of adult identity, enhancement of
the self, new object relationship, developmental milestone).
Couples may experience tension between the desire to have,
nurture and raise a child on the one hand and their sense of
responsibility on the other hand. Becoming aware of threats to
a desired pregnancy may arouse emotions in the couple,
which require attentive counselling. Research is necessary to
explore the psychological impact of genetic counselling and
offering genetic screening in preconception primary care.
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